Biotech Firm NantHealth's CEO Can't Escape Stockholder Suit
The billionaire founder and CEO of biotech startup NantHealth Inc. was left as the lone defendant in a shareholder derivative suit over a research deal in Delaware Chancery Court on Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article